ARCHIVES

News Analysis: Generic Drug Industry’s Efforts to Eliminate Shortages Raises Antitrust Law Questions

This article is from The Cancer Letter archive.

Vol. 38 No. 17 | April 27, 2012

Download PDF Visit The Full Archive

Related Articles

“Sloppy Work” May Invalidate Methylene Chloride Study; Contractor Hints NTP Pressured By Industry

October 14, 1983

In Brief: Phil Amoruso Will Be The New NCI Executive Officer; DRCCA Board Okays CCN Extension

January 2, 1981

Oncology Unit – How To Plan, Start It

February 10, 1978

Gottlieb questions ODAC’s independence.

August 5, 2005

In Brief: NCAB Vacancies Remained Unfilled; AHF’s 20thAnniversary To Be Celebrated In NY May 24

May 5, 1989

FDA to Move Away From Central Radiology To Investigator Review In PFS Endpoint Trials

July 27, 2012